Immune Suppression
Showing 1 - 25 of >10,000
Skin Diseases Trial in Birmingham (Diphenylcyclopropenone (DPCP))
Recruiting
- Skin Diseases
- Diphenylcyclopropenone (DPCP)
-
Birmingham, AlabamaWhitaker Clinic
Apr 14, 2022
HIV, Heavy Drinking Trial in Mbarara (Gabapentin, Placebo)
Not yet recruiting
- HIV
- Heavy Drinking
- Gabapentin
- Placebo
-
Mbarara, UgandaMbarara Regional Referral Hospital (MRRH): Immune Suppression Sy
Aug 19, 2022
Graft Vs Host Disease, GVHD Trial in Tampa, Minneapolis (Pacritinib, Sirolimus, Tacrolimus)
Active, not recruiting
- Graft Vs Host Disease
- GVHD
- Pacritinib
- +2 more
-
Tampa, Florida
- +1 more
Jul 27, 2022
Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)
Recruiting
- Sickle Cell Disease
- +2 more
- Fludarabine
- +7 more
-
Basking Ridge, New Jersey
- +5 more
Feb 17, 2023
Inflammatory Response, Metabolic Disturbance, Immune Suppression Trial in Kannapolis (Cranberry Juice, Placebo)
Completed
- Inflammatory Response
- +2 more
- Cranberry Juice
- Placebo
-
Kannapolis, North CarolinaAppalachian State University Human Performance Lab, North Caroli
Jan 24, 2023
Inflammatory Response, Metabolic Disturbance, Immune Suppression Trial in Kannapolis (Beet, Placebo)
Recruiting
- Inflammatory Response
- +2 more
- Beet
- Placebo
-
Kannapolis, North CarolinaAppalachian State University Human Performance Lab, North Caroli
Jun 8, 2023
Immune and Inflammatory Indices in Peripheral Blood Predict
Recruiting
- Glioma
- Immune Suppression
- Detection of Immune and Inflammatory Indices in Peripheral Blood
-
Beijing, Beijing, China
- +2 more
Dec 21, 2022
S100A8/A9 and Innate Immunity in Liver Disease
Recruiting
- Cirrhosis, Liver
- +4 more
-
London Borough Of Wandsworth, London, United KingdomArjuna Singanayagam
Mar 30, 2023
Immune Suppression, Gastric Cancer Trial in Hangzhou (nivolumab combined with SOX)
Recruiting
- Immune Suppression
- Gastric Cancer
- nivolumab combined with SOX
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Feb 11, 2023
MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Azacitidine
- +2 more
-
Stockholm, SwedenDepartment of Hematology, Karolinska University Hospital
Mar 27, 2023
Tuberculosis, HIV-1-infection, Immuno-Deficiency Trial in Worldwide (Intensified TB treatment (initial phase), WHO standard TB
Recruiting
- Tuberculosis
- +2 more
- Intensified TB treatment (initial phase)
- WHO standard TB treatment (initial phase)
-
Phnom Penh, Cambodia
- +5 more
May 3, 2022
Anesthesia Complication, Immune Suppression Trial (Deep anesthesia, Shallow anesthesia)
Completed
- Anesthesia Complication
- Immune Suppression
- Deep anesthesia
- Shallow anesthesia
- (no location specified)
May 13, 2022
Inflammatory Response, Metabolic Disturbance, Immune Suppression Trial in Kannapolis (Astaxanthin, Placebo)
Recruiting
- Inflammatory Response
- +2 more
- Astaxanthin
- Placebo
-
Kannapolis, North CarolinaAppalachian State University Human Performance Lab, North Caroli
Jun 3, 2022
Heart Transplant Rejection, Immune Suppression, Pediatric Heart Transplant Trial in Gainesville (DOT intervention)
Not yet recruiting
- Heart Transplant Rejection
- +3 more
- DOT intervention
-
Gainesville, FloridaUniversity of Florida
Feb 8, 2023
Sepsis, ARDS, Critical Illness Trial in London (Phelebotomy, Broncheoalveolar Lavage)
Not yet recruiting
- Sepsis
- +8 more
- Phelebotomy
- Broncheoalveolar Lavage
-
London, Ontario, CanadaAleks Leligdowicz
Oct 25, 2022
Kidney Transplant; Complications, Immune Suppression Trial in Oslo (Mycophenolate Mofetil 500 mg Tab, Tacrolimus capsule)
Active, not recruiting
- Kidney Transplant; Complications
- Immune Suppression
- Mycophenolate Mofetil 500 mg Tab
- Tacrolimus capsule
-
Oslo, NorwayOslo University Hospital
Apr 19, 2022
Immunocompromised Haematology Patients
Active, not recruiting
- Covid19
- +2 more
- Blood test
-
Stoke-on-Trent, United KingdomUniversity Hospitals of North Midlands NHS Trust
Feb 17, 2022
Acute Cellular Graft Rejection, New Onset Diabetes After Transplant Trial in Cincinnati (Budesonide 3Mg Capsule, Standard of
Completed
- Acute Cellular Graft Rejection
- New Onset Diabetes After Transplant
- Budesonide 3Mg Capsule
- Standard of Care Prednisone
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Jun 29, 2021
Tuberculosis, Latent Tuberculosis, HIV/AIDS Trial in Kampala (Streamlined weekly DOT visits, Weekly DOT visit reminders, Cost
Active, not recruiting
- Tuberculosis
- +2 more
- Streamlined weekly DOT visits
- +5 more
-
Kampala, UgandaMulago Immune Suppression Syndrome (ISS) Clinic
Nov 28, 2022
Pneumoperitoneum, Neuromuscular Blockade, Surgery Trial in Nijmegen (Low pressure pneumoperitoneum, Rocuronium bromide)
Completed
- Pneumoperitoneum
- +3 more
- Low pressure pneumoperitoneum
- Rocuronium bromide
-
Nijmegen, Gelderland, NetherlandsCanisius Wilhelmina Hospital
Oct 27, 2021
Vaccine Response Impaired, Immune Suppression, Covid19 Trial in Toronto (mRNA-1273 vaccine, Normal Saline Placebo)
Completed
- Vaccine Response Impaired
- +2 more
- mRNA-1273 vaccine
- Normal Saline Placebo
-
Toronto, Ontario, Canada
- +1 more
Jul 29, 2022
Cytomegalovirus Infections, Haematological Malignancy, Organ or Tissue Transplant; Complications Trial in Parkville (Blood
Enrolling by invitation
- Cytomegalovirus Infections
- +3 more
- Blood sampling
-
Parkville, Victoria, AustraliaRoyal Melbourne Hospital
Apr 28, 2022
Among HIV-1-infected Individuals With Previous or Current
Recruiting
- Covid19
- +2 more
- Immune response study
-
Madrid, SpainHospital Ramon y Cajal
Oct 23, 2021
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial
Withdrawn
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Lopinavir/Ritonavir
- +2 more
- (no location specified)
Apr 22, 2021